/
you're reading...

PetMedix enters into antibody discovery collaboration with Zoetis

PetMedix™ is pleased to announce a collaboration with Zoetis to develop novel, fully species-specific companion animal monoclonal antibody therapeutics (mAbs) using PetMedix's proprietary transgenic...

Read full story

Archives